MTEM insider filings
Molecular Templates, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-11-18. Screen MTEM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for MTEM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Molecular Templates, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-11-18 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Sale (S): 1,279,820 @ $0.66 · Purchase (P): 134,667 (derivative) @ $2.35 · Purchase (P): 769,334 (derivative) @ $0.12 | EDGAR |
| 2024-09-30 | 4 | LALANDE KEVIN M. — Director, 10% owner | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Gruia Gabriela — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | SELICK HAROLD E — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | HOFFMANN DAVE — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Sanders Corazon (Corsee) D. — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2024-04-04 | 4 | LALANDE KEVIN M. — Director, 10% owner | Grant/award (A): 175,000 @ $2.35 · Grant/award (A): 402,077 (derivative) @ $2.35 · Grant/award (A): 1,154,154 (derivative) @ $0.12 | EDGAR |
| 2024-04-04 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 250,000 @ $2.35 · Purchase (P): 134,667 (derivative) @ $2.35 · Purchase (P): 769,334 (derivative) @ $0.12 | EDGAR |
| 2024-01-25 | 4 | Voi Maurizio — Chief Medical Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Kim Jason S. — Chief Financial Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Poma Eric E — See remarks, Director | Grant/award (A): 23,333 (derivative) @ $0 | EDGAR |
| 2023-11-01 | 4 | Voi Maurizio — Chief Medical Officer | Grant/award (A): 11,333 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Gruia Gabriela — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | HOFFMANN DAVE — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | SELICK HAROLD E — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Sanders Corazon (Corsee) D. — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Lanfear Jonathan — Director | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | LALANDE KEVIN M. — Director, 10% owner | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2023-08-31 | 4 | Gruia Gabriela — Interim Chief Medical Officer, Director | Grant/award (A): 11,666 (derivative) @ $0 | EDGAR |
| 2023-07-19 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 4,255,319 @ $0.47 | EDGAR |
| 2023-02-17 | 4 | Poma Eric E — See remarks, Director | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Waltzman Roger J. — See remarks | Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Kim Jason S. — See remarks | Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2022-07-11 | 4 | Kim Jason S. — See remarks | Option exercise (M): 12,089 @ $0.71 · Option exercise (M): 12,089 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | LALANDE KEVIN M. — Director, 10% owner | Purchase (P): 100,000 @ $0.91 · Purchase (P): 60,000 @ $0.87 · Purchase (P): 62,000 @ $0.89 | EDGAR |
| 2022-06-21 | 4 | SHV Management Services, LLC — 10% owner Cunningham Joe H — 10% owner FRENCH DOUGLAS D — 10% owner SHV Management Services, LP — 10% owner SHV Annex Services, LP — 10% owner Sante Health Ventures I Annex Fund, LP — 10% owner SANTE HEALTH VENTURES I LP — 10% owner | Purchase (P): 100,000 @ $0.91 · Purchase (P): 60,000 @ $0.87 · Purchase (P): 62,000 @ $0.89 | EDGAR |
| 2022-06-21 | 4 | McLennan Sean — See remarks | Purchase (P): 30,000 @ $0.82 | EDGAR |
| 2022-06-06 | 4 | Sanders Corazon (Corsee) D. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Gruia Gabriela — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Lanfear Jonathan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | LALANDE KEVIN M. — Director, 10% owner | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | HOFFMANN DAVE — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | Hirsch David — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | SELICK HAROLD E — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-05-18 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 200,000 @ $1.18 | EDGAR |
| 2022-04-29 | 4 | Poma Eric E — See remarks, Director | Option exercise (M): 6,831 @ $0.71 · Option exercise (M): 27,325 @ $0.71 · Option exercise (M): 6,831 (derivative) @ $0 · Option exercise (M): 27,325 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Gruia Gabriela — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | Waltzman Roger J. — See remarks | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | McLennan Sean — See remarks | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | Poma Eric E — See remarks, Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | Kim Jason S. — See remarks | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 200,000 @ $4.04 | EDGAR |
| 2021-09-23 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 750,000 @ $6 | EDGAR |
| 2021-09-20 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 100,000 @ $6.13 | EDGAR |
| 2021-07-28 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 80,000 @ $7.00 · Purchase (P): 75,000 @ $7.09 | EDGAR |
| 2021-07-21 | 4 | BIOTECH TARGET N V — 10% owner BB BIOTECH AG — 10% owner | Purchase (P): 119,382 @ $6.96 · Purchase (P): 125,000 @ $7.13 | EDGAR |
| 2021-07-07 | 4 | Poma Eric E — See remarks, Director | Option exercise (M): 3,563 @ $0.71 · Option exercise (M): 3,563 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Kim Jason S. — See remarks | Option exercise (M): 32,038 @ $0.71 · Sale (S): 2,770 @ $8.36 · Option exercise (M): 32,038 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | LALANDE KEVIN M. — Director, 10% owner | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Lanfear Jonathan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Molecular Templates, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-04-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2024-12-19 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-12-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-12-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-11-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2024-10-11 | 8-K | ? | EDGAR |
| 2024-10-04 | 8-K | ? | EDGAR |
| 2024-09-27 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MTEM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs